Navigation Links
Hazardous medications
Date:2/17/2012

More than one in four elderly patients was given potentially hazardous medication during 2007. That is the conclusion of a study by Ute Amann and her co-authors in the current issue of the Deutsches rzteblatt International (Dtsch Arztebl Int 2012; 109[5]: 69-75).

Giving certain medical drug substances to over-65-year-olds can increase the risk of undesired drug effects, and for this reason experts describe them as "potentially inappropriate medications" (PIMs).

This study used information from a large database to attempt to estimate the risk of PIM for older people according to age, sex, and drug substance. The researchers used the data of 447 592 men and 356 808 women aged 65 or over to assess how often PIMs were prescribed per patient.

Women had more PIM prescriptions than men. The potentially hazardous drugs that were most often prescribed were amitriptyline, acetyldigoxin, tetrazepam, and oxazepam. Overall, 8.8% of all patients in the database received four or more prescriptions for the same or an equivalent drug during the study period.


'/>"/>
Contact: Deutsches rzteblatt International
medwiss@aerzteblatt.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related biology news :

1. Scented laundry products emit hazardous chemicals through dryer vents
2. Study suggests lower risk of coronary heart disease from alcohol, even with hazardous drinking
3. Binge drinking: Too prevalent and hazardous
4. LSU receives $3.6 million to fund center studying hazardous waste cleanup and health impacts
5. Webcam technology used to measure medications effects on the heart
6. Toward new medications for chronic brain diseases
7. Pathological gambling may be successfully treated with medications for substance addiction
8. New medications show promise in treating drug-resistant prostate cancer
9. Hypertension and cholesterol medications present in water released into the St. Lawrence River
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/8/2015)... , April 8, 2015  Infinisource, a leading ... services, and Morpho, a leading supplier of biometric ... produce the market,s most advanced biometrically-enabled time clock, ... NXG time clock is setting a bold, new ... data for the small and mid-size employer. When ...
(Date:4/2/2015)... , April 2, 2015 ... DERMALOG by far outperforms the strongest competitors, showing ... high accuracy, the system is capable of a ... speed proves up to be ten times faster ... its runner-up performance.      (Photo: ...
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2
... can produce biodiesel fuel from municipal sewage sludge that is ... conventional diesel refined from petroleum, according to an article in ... is the solid material left behind from the treatment of ... out in the article that demand for biodiesel has led ...
... part of a healthy diet, can increase the levels ... cholesterol, according to an international team of nutritional scientists., ... lowering lipids and lipoproteins, which are a risk factor ... nutrition, Penn State. "This new study shows an additional ...
... the lowly lamprey eel have identified an overlooked nervous ... circuitry in vertebrates such as birds, fishes and mammals. ... , online May 16, and highlighted in the magazine,s ... Illinois at Chicago professor of biological sciences and the ...
Cached Biology News:Pistachios offer multiple benefits 2Pistachios offer multiple benefits 3Parallel brainstem circuit discovery suggests new path in Parkinson's research 2
(Date:5/4/2015)... Boston, MA (PRWEB) May 04, 2015 ... solutions for drug discovery and life science research, ... 5.0 , the latest version of its enterprise ... for biopharma R&D enables more efficient discovery and ... holistic approach to integrate and address protein optimization ...
(Date:5/4/2015)... , May 4, 2015  Soligenix, Inc. (OTCQB: ... developing products that address unmet medical needs in the ... it will be presenting preclinical data from three of ... Defense Science and Technology Conference on May 12-14, 2015 ... at 701 Convention Plaza, St. Louis MO ...
(Date:5/4/2015)... - New Massive Open Online ... for the United States Medical Licensing Examination ... and medical information products and services, announced today that ... Course) designed to help medical students prepare for the ... first and most daunting of the three exams medical ...
(Date:5/4/2015)... May 4, 2015   Intrexon Corporation (NYSE: ... quarter 2015 financial results after the market closes on ... call that day at 5:30 PM ET to discuss ... The conference call may be accessed by dialing ... join the "Intrexon Conference Call."  Participants may also access ...
Breaking Biology Technology:Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 2Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 3Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 4Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 2Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 4Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 5Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 6Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 7Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 8Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 9Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 10Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 11Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 12Elsevier's Free MOOC Prepares Med Students for Licensing Exam 2Elsevier's Free MOOC Prepares Med Students for Licensing Exam 3Intrexon to Announce First Quarter 2015 Financial Results on Monday, May 11, 2015 2
... CardioDex announces initial commercial use ... from commercial use of the device on 41 patients at ... and no complications. "We are very excited about these new ... for a major unmet medical need due to the increasing ...
... Pa., May 1, 2012  Discovery Laboratories, Inc. (NASDAQ: ... new pharmacoeconomic analysis demonstrating that the lower rate of ... , when compared with infants treated with Curosurf ® ... leading surfactants, also resulted in a potential hospital cost ...
... 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX ) ... focused on researching, developing, manufacturing and marketing biopharmaceutical products, ... Report on Form 20-F for the fiscal year ended ... Commission on April 30, 2012. The annual report on ...
Cached Biology Technology:New Revolutionary Femoral Access Site Closure Device Shows Unparalleled Efficacy, Safety & Ease of Use, in a Wide Range of Patients Including Patients With a Challenging Anatomy 2New Revolutionary Femoral Access Site Closure Device Shows Unparalleled Efficacy, Safety & Ease of Use, in a Wide Range of Patients Including Patients With a Challenging Anatomy 3Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 2Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 3Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 4Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 5
The VersArray hybridization chamber is used for manual (coverslip) hybridization of microarrays. The chamber accommodates 2 slides and is watertight to allow incubation of slides in a water bath. Dim...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
... solid. PROTECT FROM LIGHT. Useful in cell activation experiments ... ≥98% by TLC. Soluble in DMSO or EtOH. ... 10 mM stock in DMSO is recommended. Microliter amounts ... O with rapid mixing (e.g. 10 μl into 5 ...
Monoclonal antibodies conjugated with rhodamine...
Biology Products: